Dose-response models for developmental malformations.

An empirical dose-response model can generally be found for bioassay data, which provides a mathematical relationship between the incidence of a developmental malformation and dose of a toxicant in the experimental dose range. If biological principles and data can be used in the formulation of the dose-response model, the estimation of the incidence of malformations outside of the experimental dose range may be improved. In this paper, exponential growth of morphological structures in rodents during gestation is assumed. Further, it is assumed that some structural malformations are the result of reduced or delayed growth and the incidence of structurally normal fetuses is proportional to fetal weight raised to a power. When the exponential growth rate constant is reduced by dose raised to a power, a Weibull dose-response function is obtained. When the exponential growth rate constant is modeled by a polynomial function of dose, a polynomial-exponential dose-response model is obtained. The Weibull and the polynomial-exponential model, restricted to degrees from one up to the number of dosed groups, were fit to a database of bioassay data assembled from Teratology Vol. 1 (1968) to Vol. 42 (1990). In general the two models gave similar results and often gave exactly the same fit. The linear term appeared in the polynomial-exponential model in about one-fourth of the cases and was not related to the background incidence.

[1]  R. Skalko,et al.  The teratogenic response of mouse embryos to 5-bromodeoxyuridine. , 1971, Teratology.

[2]  R. Hackman,et al.  Corticosterone-induced isolated cleft palate in A-J mice. , 1972, Teratology.

[3]  J. Spyker,et al.  Effects of methylmercury on prenatal development in mice. , 1972, Teratology.

[4]  K. Khera.  Ethylenethiourea: teratogenicity study in rats and rabbits. , 1973, Teratology.

[5]  R. Skalko,et al.  Teratogenicity of methotrexate in mice. , 1974, Teratology.

[6]  A. Druga,et al.  Action of the phenothiazine derivative methophenazine on prenatal development in rats. , 1975, Teratology.

[7]  M. Inouye,et al.  Teratogenic effect of N-methyl-N'-nitro-N-nitrosoguanidine in mice [proceedings]. , 1976, Mutation research.

[8]  K. Larsson,et al.  Studies of teratogenic effects of the dithiocarbamates maneb, mancozeb, and propineb. , 1976, Teratology.

[9]  T. Knutsen,et al.  Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice. , 1978, Teratology.

[10]  T. Fujimoto,et al.  Embryotoxic effects of methylmercuric chloride administered to mice and rats during orangogenesis. , 1978, Teratology.

[11]  Haseman Jk,et al.  Analysis of dichotomous response data from certain toxicological experiments. , 1979 .

[12]  F. Sullivan,et al.  Diazepam-induced cleft palate in the mouse: the role of endogenous maternal corticosterone. , 1980, Teratology.

[13]  B. Hales.  Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450. , 1981, Teratology.

[14]  B. N. Gupta,et al.  Teratogenic evaluation of 2-nitro-p-phenylenediamine, 4-nitro-o-phenylenediamine, and 2,5-toluenediamine sulfate in the mouse. , 1981, Teratology.

[15]  H. Spielmann,et al.  Teratogenic effects of cyproterone acetate and medroxyprogesterone treatment during the pre- and postimplantation period of mouse embryos. I. , 1982, Teratology.

[16]  T. Kusanagi.  Dose-response relations of palatal slit, cleft palate, and fetal mortality in mice treated with a glucocorticoid. , 1983, Teratology.

[17]  K S Crump,et al.  A new method for determining allowable daily intakes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[18]  T. Kusanagi.  Sensitive stages and dose-response analyses of palatal slit and cleft palate in C57BL/6 mice treated with a glucocorticoid. , 1984, Teratology.

[19]  W. B. Howard,et al.  Structure-toxicity relationships of the tetramethylated tetralin and indane analogs of retinoic acid. , 1987, Teratology.

[20]  K. Renskers,et al.  Diazepam-induced cleft palate in the mouse and lack of correlation with the H-2 locus. , 1987, Teratology.

[21]  E. J. Read,et al.  Teratogenic effects of trichloroacetonitrile in the Long-Evans rat. , 1988, Teratology.

[22]  M. Asakura,et al.  Corticosterone induction of cleft palate in mice dosed with orciprenaline sulfate. , 1988, Teratology.

[23]  C. Kimmel,et al.  Developmental toxicity evaluation of Bendectin in CD rats. , 1988, Teratology.

[24]  The mouse teratogen dinocap has lower A/D ratios and is not teratogenic in the rat and hamster. , 1988, Teratology.

[25]  Ralph L. Kodell,et al.  Quantitative Risk Assessment for Teratological Effects , 1989 .

[26]  E. J. Read,et al.  Teratogenic activity of trichloroacetic acid in the rat. , 1989, Teratology.

[27]  M. Rosen,et al.  Cyclophosphamide teratogenesis: evidence for compensatory responses to induced cellular toxicity. , 1990, Teratology.

[28]  A. Hoberman,et al.  Developmental toxicity of orally administered 2',3'-dideoxycytidine in mice. , 1990, Teratology.

[29]  D M Sheehan,et al.  Prenatal dexamethasone exposure in rats: effects of dose, age at exposure, and drug-induced hypophagia on malformations and fetal organ weights. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[30]  D. Gaylor,et al.  Process of building biologically based dose-response models for developmental defects. , 1992, Teratology.

[31]  Developmental toxicity of 2,4,5-trichlorophenoxyacetic acid (2,4,5-T). I. Multireplicated dose-response studies in four inbred strains and one outbred stock of mice. , 1992 .